Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588250 · ClinicalTrials.gov registry record · NA
Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00588250: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT00588250 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588250, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
Hypothesis: a special solution for improving human embryo implantation, when added to the solution during embryo transfer, will improve implantation rates in embryo transfers using previously frozen embryos.
Interventions
- OTHER EmbryoGlue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2003-05 |
| Est. Completion | 2005-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588250
The ClinicalTrials.gov registry entry for NCT00588250 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EmbryoGlue is the first listed.
NCT00588250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588250 about?
NCT00588250 is a clinical study titled "Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates". Hypothesis: a special solution for improving human embryo implantation, when added to the solution during embryo transfer, will improve implantation rates in embryo transfers using previously frozen embryos.
What is the current status of trial NCT00588250?
This trial is currently terminated. It is a NA study. The enrollment target is 150 participants. The study started on 2003-05. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00588250?
The interventions under investigation include: EmbryoGlue (OTHER).
Who is sponsoring clinical trial NCT00588250?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.